Physician profile
Melanie Nutter
NPI 1609843200
$2,620.39
in general payments reported to CMS, 2019-2025
19 companies · $541 in 2025
The $541 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $485 · 2022: $389 · 2023: $494 · 2024: $710 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,648 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.93 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,095.32 | 2021-2025 | |
| Janssen Biotech, INC. | $463.73 | 2021-2025 | Stelara, Tremfya |
| Celgene Corporation | $214.32 | 2021-2024 | Zeposia |
| Pfizer INC. | $159.54 | 2021-2025 | |
| Redhill Biopharma INC. | $105.47 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.22 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.15 | 2021-2025 | Eohilia |
| Ardelyx, INC. | $64.50 | 2022-2025 | Ibsrela |
| Celltrion USA INC. | $61.46 | 2024-2025 | Vegzelma |
| Genzyme Corporation | $55.46 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $44.46 | 2024-2025 | Dupixent |
| Daiichi Sankyo INC. | $40.83 | 2022-2024 | Injectafer |
| Medtronic, INC. | $27.74 | 2024 | Interstim |
| Phathom Pharmaceuticals, INC. | $24.39 | 2023-2025 | Voquezna |
| Pharmacosmos Therapeutics INC. | $21.74 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $19.39 | 2025 | Sucraid |
| Nestle Healthcare Nutrition INC. | $18.69 | 2021 | |
| Mallinckrodt Hospital Products INC. | $17.22 | 2023 | Terlivaz |
| Ferring Pharmaceuticals INC. | $15.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Nutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.